| 标题 |
Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX |
| 网址 | |
| DOI |
10.1097/coc.0000000000000193
doi
|
| 其它 |
期刊:American Journal of Clinical Oncology 作者:Renata D. Peixoto; Maria Ho; Daniel J. Renouf; Howard J. Lim; Sharlene Gill; et al 出版日期:2017-10-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)